Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BCAP29 | FIMM | pan-cancer | AAC | 0.45 | 0.007 |
mRNA | MOB1A | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
mRNA | TEX2 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
mRNA | SLITRK4 | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
mRNA | SNX5 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
mRNA | THBS2 | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
mRNA | KLK10 | CCLE | pan-cancer | AAC | 0.15 | 0.007 |
mRNA | FHL1 | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
mRNA | VIM | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
mRNA | GUCY1A3 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |